About Us
Transforming the world through the discovery and detection of complex genetic changes
About KromaTiD
We provide single-cell, cytogenetic analysis that enables today’s most innovative developments in cell and gene therapy.
Whether looking at the entire genome or a specific locus, our dGH™ platform allows researchers to visualize complex structural rearrangements that PCR and sequencing-based platforms miss, ensuring that the therapies of tomorrow are designed safely today.
Why KromaTiD?
Navigating Complexity: Developing groundbreaking therapies involves intricate processes, from lab experiments to commercialization. At KromaTiD, our technical team, with 13 years of experience, meticulously confirms the validity of the genome using our single-cell assays. You can move forward with confidence, knowing that we’ve got your back.
Seamless Collaboration and Customized Services: Our partnerships go beyond handshakes. We actively collaborate with you, ensuring smooth transitions from research insights, regulatory guidance, to clinical trials, through commercialization. KromaTiD tailors its services to fit your unique needs.
Patient Impact: Ultimately, it’s about the patients. KromaTiD’s commitment ensures that novel therapeutics reach those who depend on them for hope and healing. Our goals align with yours—we’re driven by the same purpose: improving lives through innovative therapies.
Unlock the potential of cell and gene therapies with KromaTiD—an extension of your team—by your side.